Neuropace, Inc. NPCE Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s investing cash flow?
- Neuropace, Inc. (NPCE) reported investing cash flow of -$117K in Q1 2026.
- How has Neuropace, Inc.'s investing cash flow changed year-over-year?
- Neuropace, Inc.'s investing cash flow decreased by 216.2% year-over-year, from -$37K to -$117K.
- What is the long-term trend for Neuropace, Inc.'s investing cash flow?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s investing cash flow has grown at a -75.0% compound annual growth rate (CAGR), from -$85.4M to -$332K.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.